Triple-Hormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial
Weight of evidence: Overall evidence is Low-Moderate: multiple animal studies and a growing number of small clinical trials suggest benefits across gutbrain signaling, social and behavioral domains, gastrointestinal symptoms, and neurophysiological patterns, yet most human studies rely on caregiver-reported outcomes, lack biomarker integration, and seldom control for diet, comorbidities, or baseline microbiome composition
Additionally, amylin receptor stimulation helps regulate postprandial glucose levels by curbing the rapid rise of blood sugar after eating
If free radicals accumulated in the body are not removed, problems such as wrinkles, broken nails and hair loss become inevitable
Bioactivation of luteolin by tyrosinase selectively inhibits glutathione S-transferase